While willin might act as a tumour suppressor, like merlin, only a background frequency of willin mutations have been reported in cancer at present (http://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=FRMD6), so it is difficult to argue that these are driver mutations in cancer. The gene discussed is FRMD6; the disease is cancer.